Description
The skeptic noted that comparing absolute phosphorylation levels doesn’t reveal whether mutant LRRK2 has altered stimulus-response dynamics. Understanding the temporal profile and amplitude of the volume-sensing response is essential for mechanism-based drug development.
Source: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352 (Analysis: SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867)
Resolution criteria
Resolved when an evidence artifact defines the dynamic range and kinetics of LRRK2 substrate phosphorylation during lysosomal volume sensing with one of: (1) quantitative phosphoproteomics (TMT-MS or phosphoarrays) in patient-derived lymphoblastoid cell lines or iPSC-derived neurons comparing G2019S LRRK2 versus WT, measuring >=3 timepoints (0, 15, 30, 60, 120 min) after lysosomal swelling induction (by LLOME or chloroquine), demonstrating altered stimulus-response kinetics (>=2-fold change in EC50 or max amplitude) with FDR < 0.05; (2) live-cell biosensor imaging (phospho-specific LRRK2 reporter) in G2019S versus WT neurons showing altered fluorescence recovery half-life (t1/2) after osmotic challenge, with n >= 20 cells per genotype; (3) in vitro kinase assay with purified LRRK2 G2019S versus WT, recombinant LRRK2 substrates (Rab10, Rab12, Rab29), and increasing ATP concentrations, establishing whether the mutation increases KM or Vmax for ATP or substrate. Quantitative thresholds: AUROC >= 0.85 for stimulus-response discrimination between genotypes.
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:30.027536+00:00”, “resolution_summary”: “Resolved by hypothesis h-d4ac0303f6: G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain. Supporting evidence includes debate sess_SDA-2026-04-23-gap-debate-20260417-033119-54941818_task_9aae8fc5.”, “match_counts”: {“hypothesis_matches”: 3, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-d4ac0303f6”, “title”: “G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain”, “score”: 0.287, “reason”: “7 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-25-gapdebate-9180363b7c”, “target_gene”: “LRRK2”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.79, “confidence_score”: 0.32, “status”: “proposed”, “pubmed_evidence_ids”: [“23066449”, “34125248”, “34686322”, “35580815”, “35907404”]}, {“id”: “h-a0269f3c81”, “title”: “G2019S Acts as Lysosomal Volume-Sensing Amplifier via Enhanced RAB29-Dependent Recruitment (H1)”, “score”: 0.285, “reason”: “7 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “target_gene”: “LRRK2,RAB29”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.73, “confidence_score”: 0.72, “status”: “proposed”, “pubmed_evidence_ids”: [“28165311”, “30635564”, “33135724”, “33177079”, “33448356”]}, {“id”: “h-75fd56f128”, “title”: “RAB29 Is the Critical Molecular Switch That Determines Whether LRRK2 Signal Amplification Occurs (H4)”, “score”: 0.225, “reason”: “4 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “target_gene”: “RAB29”, “target_pathway”: null, “disease”: “neurodegeneration”, “composite_score”: 0.71, “confidence_score”: 0.7, “status”: “proposed”, “pubmed_evidence_ids”: [“28067317”, “30635564”, “31743699”, “33135724”, “33177079”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-23-gap-debate-20260417-033119-54941818_task_9aae8fc5”, “title”: “The debate highlighted that G2019S shows elevated baseline RAB10 phosphorylation, but it’s unclear whether this represents true signal amplification during lysosomal swelling or just a higher activity floor. This distinction is crucial for understanding disease mechanisms and therapeutic targeting.\n\nSource: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352 (Analysis: SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867)”, “score”: 0.465, “reason”: “12 token overlaps; entity overlap: sda-2026-04-16-”, “analysis_id”: “SDA-2026-04-23-gap-debate-20260417-033119-54941818”, “quality_score”: 0.801, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867_20260416-135352”, “title”: “While the study establishes LRRK2 as a lysosomal swelling sensor and notes that lysosomal swelling occurs in LRRK2-linked diseases, it doesn’t directly test whether pathogenic LRRK2 mutations alter this volume-sensing function. This connection is crucial for understanding how LRRK2 mutations cause Parkinson’s disease and related disorders.\n\nGap type: open_question\nSource paper: Lysosomal swelling triggers LRRK2 activity. (2026, bioRxiv : the preprint server for biology, PMID:41427358)”, “score”: 0.418, “reason”: “11 token overlaps; entity overlap: lrrk2”, “analysis_id”: “SDA-2026-04-16-gap-pubmed-20260410-170027-a1e5f867”, “quality_score”: 0.85, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “wrap_SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2_1776594195”, “title”: “The fundamental premise remains unvalidated despite extensive mechanistic speculation. Independent validation using purified proteins and orthogonal binding assays is essential before pursuing mechanistic studies. This determines whether any C1q-related effects are direct or indirect.\n\nSource: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e (Analysis: SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e)”, “score”: 0.293, “reason”: “6 token overlaps; entity overlap: sda-2026-04-16-”, “analysis_id”: “SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2”, “quality_score”: 1.0, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2”, “title”: “The fundamental premise remains unvalidated despite extensive mechanistic speculation. Independent validation using purified proteins and orthogonal binding assays is essential before pursuing mechanistic studies. This determines whether any C1q-related effects are direct or indirect.\n\nSource: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e (Analysis: SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e)”, “score”: 0.293, “reason”: “6 token overlaps; entity overlap: sda-2026-04-16-”, “analysis_id”: “SDA-2026-04-17-gap-debate-20260417-033037-c43d12c2”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-21-gap-debate-20260417-033037-c43d12c2_20260421-021018”, “title”: “The fundamental premise remains unvalidated despite extensive mechanistic speculation. Independent validation using purified proteins and orthogonal binding assays is essential before pursuing mechanistic studies. This determines whether any C1q-related effects are direct or indirect.\n\nSource: Debate session sess_SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e (Analysis: SDA-2026-04-16-gap-pubmed-20260410-095709-4e97c09e)”, “score”: 0.293, “reason”: “6 token overlaps; entity overlap: sda-2026-04-16-”, “analysis_id”: “SDA-2026-04-21-gap-debate-20260417-033037-c43d12c2”, “quality_score”: 0.5, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}